Whittlestone is proud to present results of the first completed Clinical Trial of our Breast Expresser, conducted by Health and Nutrition, Inc., of Reno, Nevada. The data in this report shows a very high degree of success with our Expresser in the relief of even severe cases of breast engorgement. This serious condition threatens lactation, causing pain to the mother while denying adequate Breastmilk to the baby. We are pleased that our Expresser has been shown to bring painless relief to the mothers so quickly and that all babies were able to latch on to the breast and transfer milk.
Click here to read the report in .pdf (Adobe Acrobat) format.